The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term outcomes of cisplatin-based chemotherapy in patients with stage II-III germ cell tumors: Center 30-year experience of a single center.
Guillermo De Velasco
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose
Juan Manuel Sepúlveda
No relevant relationships to disclose
Felipe Villacampa
No relevant relationships to disclose
Tomas Pascual
No relevant relationships to disclose
Ray Manneh
No relevant relationships to disclose
Lucia Parrilla
No relevant relationships to disclose
Carlos A. Farfán
No relevant relationships to disclose
Hernan Cortes-Funes
No relevant relationships to disclose